Skip to main content
Top
Literature
1.
go back to reference Rifkin E, Cheng T. The origin, structure and histochemical characterization of encapsulating cysts in the oyster Crassostrea virginica parasitized by the cestode Tyocephalum sp. J Invertebr Pathol 1968; 10: 54–64PubMedCrossRef Rifkin E, Cheng T. The origin, structure and histochemical characterization of encapsulating cysts in the oyster Crassostrea virginica parasitized by the cestode Tyocephalum sp. J Invertebr Pathol 1968; 10: 54–64PubMedCrossRef
2.
go back to reference LaKind J, Rifkin E. Current method for setting dioxin limits in water requires reexamination. Environ Sci Technol 1990; 24(7): 963–5CrossRef LaKind J, Rifkin E. Current method for setting dioxin limits in water requires reexamination. Environ Sci Technol 1990; 24(7): 963–5CrossRef
3.
go back to reference Rifkin E, LaKind J. Dioxin bioaccumulation: key to a sound risk assessment methodology. J Toxicol Environ Health 1991; 33: 103–12PubMedCrossRef Rifkin E, LaKind J. Dioxin bioaccumulation: key to a sound risk assessment methodology. J Toxicol Environ Health 1991; 33: 103–12PubMedCrossRef
4.
go back to reference Rifkin E, Bouwer E. A proposed approach for deriving national sediment criterion for dioxin. Environ Sci Technol 1994; 14(9): 441–3CrossRef Rifkin E, Bouwer E. A proposed approach for deriving national sediment criterion for dioxin. Environ Sci Technol 1994; 14(9): 441–3CrossRef
5.
go back to reference Rifkin E, Bouwer E. The illusion of certainty: health benefits and risks. New York: Springer Science and Business Media, 2007CrossRef Rifkin E, Bouwer E. The illusion of certainty: health benefits and risks. New York: Springer Science and Business Media, 2007CrossRef
6.
go back to reference Stamler J, Wentworth D, Neaton JD. Is the relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356 222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 1986; 256(2): 2823–8PubMedCrossRef Stamler J, Wentworth D, Neaton JD. Is the relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356 222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 1986; 256(2): 2823–8PubMedCrossRef
7.
go back to reference Golomb BA, Criqui MH, White H, et al. Conceptual foundations of the UCSD statin study: a randomized controlled trial assessing the impact of statins on cognition, behavior, and biochemistry. Arch Intern Med 2004; 164(2): 153–62PubMedCrossRef Golomb BA, Criqui MH, White H, et al. Conceptual foundations of the UCSD statin study: a randomized controlled trial assessing the impact of statins on cognition, behavior, and biochemistry. Arch Intern Med 2004; 164(2): 153–62PubMedCrossRef
8.
go back to reference Jacobs DR, Adachi H, Mulder I, et al. Cigarette smoking and mortality risk: twenty-five-year follow-up of the Seven Countries Study. Arch Intern Med 1999; 159: 733–40PubMedCrossRef Jacobs DR, Adachi H, Mulder I, et al. Cigarette smoking and mortality risk: twenty-five-year follow-up of the Seven Countries Study. Arch Intern Med 1999; 159: 733–40PubMedCrossRef
9.
go back to reference Jarvelin M. The illusion of certainty: health benefits and risks [review]. N Engl J Med 2008 Mar; 358: 10CrossRef Jarvelin M. The illusion of certainty: health benefits and risks [review]. N Engl J Med 2008 Mar; 358: 10CrossRef
Metadata
Title
Erik Rifkin, PhD
Writer, Researcher, Patient, and Citizen Advocate
Author
Jennifer Chang
Publication date
01-07-2008
Publisher
Springer International Publishing
Published in
The Patient - Patient-Centered Outcomes Research / Issue 3/2008
Print ISSN: 1178-1653
Electronic ISSN: 1178-1661
DOI
https://doi.org/10.2165/1312067-200801030-00001

Other articles of this Issue 3/2008

The Patient - Patient-Centered Outcomes Research 3/2008 Go to the issue

Original Research Article

The Burden of Restless Legs Syndrome

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine